Pipeline

Progress of Programs

Stage
Jun 30, 2018
Sep 30, 2018
Number of Ongoing Programs
84 89
Hit-to-Lead Stage
34 34
Lead-to-Preclinical
8 8
Clinical Candidates
4 4
Phase 1 Clinical Study
2 2
Phase 2 Clinical Study
0 0
Phase 3 Clinical Study
0 0